Return to homepagePandemic Pact

DEVELOPMENT OF A COMPOUND FOR THE TREATMENT OF COVID-19

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N93023C00052-0-9999-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023
    2026

  • Known Financial Commitments (USD)

    $8,469,477

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    STANLEY WANG

  • Research Location

    United States of America

  • Lead Research Institution

    ALIGOS THERAPEUTICS, INC.

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

To support the advanced development of a promising antiviral against a pathogen with pandemic potential. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.